The $2.16 billion “nuclear bomb” detonates tomorrow! $BTC Longs and shorts battle at $83k—retail investors, don’t rush to bottom-fish!
BTC is currently around $82.5k, ETH has fallen below the $2,600 level, and market sentiment has hit rock bottom.
Around $2.16 billion worth of BTC and $ETH options will expire tomorrow. BTC’s max pain is $84k, while ETH’s is $2,650. The Put/Call ratios have reached 1.12 and 0.71, respectively, with the overall market leaning bearish.
Personal view: Implied volatility is currently low, and buyers are unwilling to pay a premium to bet on a direction, so the mar

JUST IN: US Bitcoin ($BTC) spot ETFs logged a $485 million net outflow, the largest since June.
BlackRock and Fidelity's combined positions matter here, institutional appetite is cooling.

Did you catch this market move? ZEC short profits secured!
$ZEC Entered at 1334 and took profit at 1230, securing 104 points of profit
Pocketed 3,000 U, with a 760.83% return!!!
This move took the bro account straight to 110,000 U
Still don't know how to recover your losses and multiply your account?
Catch the rhythm and set sail together
#GateMoney正式上线
#美联储9月纪要偏鹰
#三星Q3营业利润飙升782.5%

We managed to hold on as well. There are still opportunities for short-term long positions around 82,000 and 80,800. The overall trend is bearish; if the monthly bearish trend continues to play out, the profits from the pullback over these two months could still be considerable.

The Fed Pauses Rate Hikes—Can the Crypto Market Finally Breathe a Sigh of Relief?
The toughest part of this market cycle is that expectations for an October rate hike have fallen, yet the market has not relaxed. The Fed already raised rates by 25 basis points in September, bringing the rate to 3.75%–4%. The latest minutes show that most officials still believe another rate hike this year may be appropriate. A temporary pause is still a long way from easing.
Look at the actual data: During the Asian session on October 8, the U.S. Dollar Index was around 102.25, the U.S. 10-year Treasury yield r

I took a trip to Luoyang during the holiday and really couldn't resist recommending it to everyone~💕
The atmosphere in Luoyang is truly amazing. The ancient city, night views, and food all have their own unique charm, and you can get great photos just by strolling around📸. Especially at night, once the lights come on, it really feels like you've traveled back to ancient times✨
If you're also looking for somewhere to relax recently, Luoyang is definitely worth adding to your itinerary!
#美国政府地址32小时转出6.7亿美元加密资产

I’ve never seen a country put their senior citizens to work like Singapore
With both of my parents over 60
This truly warms my heart
One of them told me “having a purpose”
Is all that matters age is just a number

🎉Welcome, new partners!
Embark on a new learning journey. The market is full of opportunities—keep your own pace, move forward steadily, and let's quietly await the harvest together.✨

Truly authentic clay-pot cooking,
A group of people gathered around to eat together—it just tastes so good🍲

$ETH The outlook is still leaning bearish today～😗 After yesterday’s sharp sell-off, the short-term structure has not clearly recovered, and the rebound has also been relatively weak, indicating that selling pressure above remains.
Focus on the 2600-2650 resistance zone. If the rebound continues to fail to hold steadily, bears may still have room to extend the downward move. First watch the area around 2540 below; once it effectively breaks, pay further attention to the 2500 and even 2400 areas.
However, this kind of post-crash market is not suitable for blindly chasing shorts. Patiently wait

While range-bound traders chop inside mid-range consolidation, this technical structure on $ETH is holding above key pivot support for a retest of 1st Resistance.
After completing a strong impulse leg from the 100% Fib low at $2,353.59 to local highs near $2,807.64 , price pulled back to establish a firm higher-low base. Currently trading around $2,725.69 , price continues to build higher-low structure above the Pivot level at $2,644.39 (38.20% Fib), keeping the bullish bias intact for an upward continuation push.
Holding above the $2,644.39 Pivot level maintains the bullish trajectory towar

It’s getting recovery before pump starts

Those still holding trapped long positions, the repeated choppy consolidation during this period has put heavy pressure on your positions. You’ve worked hard—don’t easily give up your chips.
The ultimate defensive zone for this pullback remains locked around 80000-78000, while the target high for the second-wave rebound is still 90000. The broader direction has not changed.
Those holding long positions must strictly control their position sizes and remain alert to liquidation risks at all times. There is no standard answer for adding to positions—make decisions based on your own risk tolerance

Guys, there’s a reason prices can’t move higher right now.
Yesterday’s meeting minutes were released, but they had absolutely no impact on the broader market—there was no reaction whatsoever!
The main reason is that there are too many people going long, with retail longs everywhere.
Whether it’s Bitcoin or Ethereum, retail traders going long are everywhere.
Under this macro pressure and in these market conditions, with so many retail traders going long, the market makers’ willingness to push prices higher is naturally very low.
Look at $ETH : it was dumped from 2725 to 2536, and now i

$BTC Yesterday's strategy:
Went long on BTC near 83550 and were prompted to close near 83900, successfully turning a profit.
Went long on SNDK near 1626.3, entering near the lowest point; it rebounded to around 1733 at the high, successfully turning a profit.

I need a #Memecoin
Low market cap
Shill me tickers #____

Which underated #Altcoin is here Right Now!
Shill me your moon bag, am buying #___

Google-affiliated AI pharma company Isomorphic Labs’ new valuation: $40–50 billion, roughly 3x TEM+RXRX+SDGR
1｜What the company has now
- UK company’s 2025 annual report: operating revenue of 0; payments from pharma partnerships recorded as other income of £55.23 million; R&D expenses of £190 million; net loss of £159 million; average headcount of 225.
- Its key cards are pharma partnerships: Eli Lilly $LLY with milestones of up to $1.7 billion, Novartis $NVS up to $1.2 billion, and it also signed Johnson & Johnson $JNJ this January. Milestones are installment payments that pharma companies